Septic shock due to community-acquired Pseudomonas aeruginosa necrotizing fasciitis: A case report and literature review

Experimental and Therapeutic Medicine

Volumn 7, Issue 6, 2014, Pages 1545-1548

  Zhao, Guang Ju ^a   Hong, Guang Liang ^a   Liu, Jie Quan ^a   Lu, Yang ^a   Lu, Zhong Qiu ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Necrotizing fasciitis; Pseudomonas aeruginosa; Septic shock

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; CREATINE KINASE MB; IMMUNOGLOBULIN; LINEZOLID; NORADRENALIN; PIPERACILLIN PLUS TAZOBACTAM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TEICOPLANIN;

AGED; ALKALOSIS; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; BREATHING RATE; CASE REPORT; CENTRAL VENOUS PRESSURE; COMMUNICABLE DISEASE; CYANOSIS; ECHOGRAPHY; ENDOTRACHEAL INTUBATION; FEVER; FLUID RESUSCITATION; HEART RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; LEUKOCYTE COUNT; LIMB SWELLING; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; NECROTIZING FASCIITIS; NEUTROPENIA; PERIPHERAL EDEMA; PSEUDOMONAS AERUGINOSA; RHABDOMYOLYSIS; SEPTIC SHOCK; SKIN INCISION; SURGICAL DRAINAGE; THROMBOCYTE COUNT; TISSUE NECROSIS; TREATMENT OUTCOME; VEIN THROMBOSIS;

EID: 84898490273     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1628     Document Type: Article

References (13)

1. Sarani B, Strong M, Pascual J and Schwab CW: Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg 208: 279-288, 2009.
2. Akamine M, Miyagi K, Uchihara T, et al: Necrotizing fasciitis caused by Pseudomonas aeruginosa. Intern Med 47: 553-556, 2008.
3. Anaya DA and Dellinger EP: Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 44: 705-710, 2007.
4. Crawford J, Ozer H, Stoller R, et al: Reduction by granulocyte-colony stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325: 164-170, 1991.
5. Dellinger RP, Levy MM, Rhodes A, et al: Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41: 580-637, 2013.
6. Gaieski DF, Mikkelsen ME, Band RA, et al: Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38: 1045-1053, 2010.
7. Rimmelé T and Kellum JA: Clinical review: blood purification for sepsis. Crit Care 15: 205, 2011.
8. Honore PM, Jacobs R, Joannes-Boyau O, et al: Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments. Ann Intensive Care 1: 32, 2011.
9. Roberts DM, Roberts JA, Roberts MS, et al: Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. Crit Care Med 40: 1523-1528, 2012.
10. Mueller SC, Majcher-Peszynska J, Hickstein H, et al: Pharmacokinetics of piperacillin-tazobactam in anuric intensive care patients during continuous venovenous hemodialysis. Antimicrob Agents Chemother 46: 1557-1560, 2002.
11. Kobayashi L, Konstantinidis A, Shackelford S, et al: Necrotizing soft tissue infections: delayed surgical treatment is associated with increased number of surgical debridements and morbidity. J Trauma 71: 1400-1405, 2011.
12. Phan HH and Cocanour CS: Necrotizing soft tissue infections in the intensive care unit. Crit Care Med 38: S460-S468, 2010.
13. Hong GL, Lu CJ, Lu ZQ, et al: Surgical treatment of 19 cases with vibrio necrotising fasciitis. Burns 38: 290-295, 2012.